451 related articles for article (PubMed ID: 12868245)
1. [Nosocomial methicillin-resistant staphylococci that remain sensitive to non-beta lactam antibiotics].
Manfredi R; Nanetti A; Morelli S; Valentini R; Ferri M; Calza L; Chiodo F
Recenti Prog Med; 2003; 94(7-8):344. PubMed ID: 12868245
[No Abstract] [Full Text] [Related]
2. [Are we being threatened by multiresistant strains of Staphylococcus aureus?].
Aepfelbacher M
MMW Fortschr Med; 2005 Jan; 147(4):33-5, 37. PubMed ID: 15745339
[TBL] [Abstract][Full Text] [Related]
3. [Determination of the in vitro activity of 2 glycopeptides (vancomycin and teicoplanin) against methicillin-resistant Staphylococcus aureus of intrahospital origin].
Gil M; Otth L; Wilson M; Arce E; Zaror A; Lizama V
Rev Med Chil; 2000 Jan; 128(1):111-2. PubMed ID: 10883531
[No Abstract] [Full Text] [Related]
4. Nosocomial methicillin--resistant Staphylococcus aureus with reduced susceptibility to vancomycin.
Bhat G; Kamath S; Hussain A
Indian J Pathol Microbiol; 2006 Apr; 49(2):311-2. PubMed ID: 16933753
[No Abstract] [Full Text] [Related]
5. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
[TBL] [Abstract][Full Text] [Related]
6. Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit.
Cepeda J; Hayman S; Whitehouse T; Kibbler CC; Livermore D; Singer M; Wilson AP
J Antimicrob Chemother; 2003 Sep; 52(3):533-4. PubMed ID: 12888581
[No Abstract] [Full Text] [Related]
7. Emergence of vancomycin-intermediate Staphylococcus aureus and S. sciuri, Greece.
Tsakris A; Papadimitriou E; Douboyas J; Stylianopoulou F; Manolis E
Emerg Infect Dis; 2002 May; 8(5):536-7. PubMed ID: 11996696
[No Abstract] [Full Text] [Related]
8. An outbreak of Staphylococcus aureus strains with reduced susceptibility to glycopeptides in a French general hospital.
Pina P; Marliere C; Vandenesch F; Bedos JP; Etienne J; Allouch PY
Clin Infect Dis; 2000 Nov; 31(5):1306-8. PubMed ID: 11073773
[TBL] [Abstract][Full Text] [Related]
9. [Use of glycopeptides in the treatment of infections caused by methicillin-resistant staphylococci].
Bouza E; Rodríguez-Créixems M; Muñoz P
Rev Clin Esp; 1997 Sep; 197 Suppl 2():52-8. PubMed ID: 9441324
[No Abstract] [Full Text] [Related]
10. Microbiological indications for the treatment of Staphylococcus aureus infections.
Fabbri A; Tacchella A; Belli ML; Losurdo G
Chemioterapia; 1988 Dec; 7(6):378-81. PubMed ID: 3219748
[TBL] [Abstract][Full Text] [Related]
11. Comment on: Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
Hmouda H; Ben Salem C; Bouraoui K; Jemni L
J Antimicrob Chemother; 2006 Dec; 58(6):1307; author reply 1307-8. PubMed ID: 17056611
[No Abstract] [Full Text] [Related]
12. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
Cartolano GL; Cheron M; Benabid D; Leneveu M; Boisivon A;
Clin Microbiol Infect; 2004 May; 10(5):448-51. PubMed ID: 15113324
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of vancomycin and teicoplanin against staphylococci in intensive care units.
Kucukates E
Natl Med J India; 2004; 17(2):117. PubMed ID: 15141614
[No Abstract] [Full Text] [Related]
14. In vitro activity of oxacillin, vancomycin and teicoplanin against staphylococci isolated from patients on surgical and coronary intensive care units.
Kucukates E; Nalan Karayel E; Gultekin N; Okuyan E; Kansiz E; Gurler N
Int J Antimicrob Agents; 2004 Aug; 24(2):193-4. PubMed ID: 15288323
[No Abstract] [Full Text] [Related]
15. Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital.
Mallaval FO; Carricajo A; Delavenna F; Recule C; Fonsale N; Manquat G; Raffenot D; Rogeaux O; Aubert G; Tous J
Clin Microbiol Infect; 2004 May; 10(5):459-61. PubMed ID: 15113326
[TBL] [Abstract][Full Text] [Related]
16. [Resistance spectrum of staphylococci at the Vienna general hospital (July to December 1991)].
Aspöck C; Koller W; Rotter M; el Madani N; Seper E; Chizzali-Bonfadin C; Chizzali-Bonfadin C
Wien Klin Wochenschr; 1994; 106(1):20-6. PubMed ID: 8135027
[TBL] [Abstract][Full Text] [Related]
17. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
Huang JH; Hsu RB
Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
[TBL] [Abstract][Full Text] [Related]
18. Methicillin-resistant Staphylococcus aureus: a community concern.
Hedge DD
S D Med; 2006 Oct; 59(10):433, 435. PubMed ID: 17124921
[No Abstract] [Full Text] [Related]
19. [Susceptibility to selected chemotherapeutics of Staphylococcus aureus strains resistant to methycyline isolated from clinical materials in the years 1991-1992 and 1997].
Kochman M; Fordymacki P; Lawrynowicz-Paciorek M; Kałuzewski S; Mészáros J; Połowniak-Pracka H; Ochman E; Sztandar-Sztanderska M
Med Dosw Mikrobiol; 1999; 51(3-4):187-98. PubMed ID: 10803247
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin, unbeatable for methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia? Really?
Luna CM; Bruno D; Aruj P
Crit Care Med; 2010 Sep; 38(9):1910-2. PubMed ID: 20724890
[No Abstract] [Full Text] [Related]
[Next] [New Search]
